<table border="1"><tr><th>Type</th><td>Public</td></tr><tr><th>Traded as</th><td>NYSE: LLY | S&amp;P 100 component | S&amp;P 500 component</td></tr><tr><th>ISIN</th><td>US5324571083</td></tr><tr><th>Industry</th><td>Pharmaceutical</td></tr><tr><th>Founded</th><td>1876 | ; 146 years ago</td></tr><tr><th>Founder</th><td>Eli Lilly</td></tr><tr><th>Headquarters</th><td>Indianapolis, Indiana, U.S.</td></tr><tr><th>Key people</th><td>David A. Ricks | (Chairperson, President, &amp; CEO) |  Anat Ashkenazi | (Vice president &amp; CFO)</td></tr><tr><th>Products</th><td>Pharmaceutical drugs</td></tr><tr><th>Revenue</th><td>US$22.319 billion | (2019)</td></tr><tr><th>Operating income</th><td>US$5.595 billion | (2019)</td></tr><tr><th>Net income</th><td>US$8.318 billion | (2019)</td></tr><tr><th>Total assets</th><td>US$39.286 billion | (2019)</td></tr><tr><th>Total equity</th><td>US$2.699 billion | (2019)</td></tr><tr><th>Owner</th><td>Lilly Endowment, 11.6%</td></tr><tr><th>Number of employees</th><td> 33,625 | (2019)</td></tr><tr><th>Website</th><td>www | .lilly | .com</td></tr></table>